- B.S. Chemical Engineering, Florida State University
- Ph.D. Chemical and Biomolecular Engineering, Johns Hopkins University
- American Institute of Chemical Engineers
- Biomedical Engineering Society
- Biophysical Society
- Controlled Release Society
- American Thoracic Society
Selected Honors and Awards
- 2021: NSF CAREER Award
- 2020: BMES-CMBE Rising Star Award
- 2019: American Lung Association Innovation Award
- 2019: Langmuir Early Career Advisory Board Member
- 2018: Oak Ridge Associated Universities Ralph E. Powe Junior Faculty Award
- 2017: Burroughs Wellcome Fund Career Award at the Scientific Interface
Complex biological fluids & interfaces, nanoparticle drug delivery, viral gene delivery, respiratory infection, lung diseases
Our research is focused on using nanotechnology and bioengineering as tools to broaden understanding of the lung airway microenvironment in order to develop state-of-the-art diagnostic and therapeutic approaches. These efforts are built on our group’s expertise in designing novel measurement schemes and bioengineered models, capable of shedding new light on previously unstudied aspects of the lung airways. The nature of this work requires an interdisciplinary and collaborative approach where we work closely with basic and clinical scientists in order to successfully work towards our research goals. Specific areas of interest in our laboratory include:
- Lung airway mucus clearance in health & disease
- Host-pathogen interactions in respiratory infections (e.g. influenza)
- Engineering mucin biomaterials for biology & medicine
- Overcoming biological barriers to drug & gene delivery
BIOE331 - Biofluids
BIOE689R - Biopolymers
- Joyner K, Song D, Hawkins R, Silcott R, Duncan GA. “A rational approach to form disulfide-linked mucin hydrogels”. Soft Matter. 15, 9632-9639, 2019.
- Duncan GA, Kim N, Colon-Cortes Y, Rodriguez J, Mazur M, Birket SE, Rowe SM, West NE, Livraghi-Butrico A, Boucher RC, Hanes J, Aslanidi G, Suk JS. “An adeno-associated viral vector capable of penetrating the mucus barrier to inhaled gene therapy”. Molecular Therapy: Methods & Clinical Development. 9, 296-304, 2018.
- Duncan GA, Jung J, Joseph A, Thaxton AL, West NE, Boyle MP, Hanes J, Suk JS. “Microstructural Alterations of Sputum in Cystic Fibrosis Lung Disease”. JCI Insight, 1(18), e88198, 2016.
- Duncan GA, Jung J, Hanes J, Suk JS. “The Mucus Barrier to Inhaled Gene Therapy”. Molecular Therapy. 24(12), 2043-53, 2016.
Full listing of publications available on Google Scholar.